Susquehanna International Group
PTPI

Susquehanna International Group’s Petros Pharmaceuticals PTPI Stock Holding History

Susquehanna International Group’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-114
Closed -$15K – 13415
2022
Q3 		$15K Buy
+114
New +$20.7K ﹤0.01% 12700
2022
Q2 		– Sell
-211
Closed -$82K – 13729
2022
Q1 		$82K Buy
211
+55
+35% +$23.2K ﹤0.01% 12036
2021
Q4 		$130K Buy
+156
New +$91.4K ﹤0.01% 11953

Other funds holding PTPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's PTPI Position: Q4 2022 in Review

Susquehanna International Group sold out of Petros Pharmaceuticals (PTPI) in Q4 2022, closing a stake of 72 shares — an estimated $9K sold.

Susquehanna International Group first reported a position in PTPI in Q4 2021 and held it in 3 quarters. The position peaked at $225K in Q4 2021. 7 funds tracked by Wall St. Rank hold PTPI as of Q4 2022.

  • Susquehanna International Group reported no remaining Petros Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 72 Petros Pharmaceuticals shares in Q4 2022, an estimated $9K.
  • Susquehanna International Group first reported a position in Petros Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Susquehanna International Group's Petros Pharmaceuticals position peaked at $225K in Q4 2021.
  • 7 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.